Data Insights

BGB-15025 by BeiGene for Non-Small Cell Lung Cancer: Likelihood of Approval

BGB-15025 is under clinical development by BeiGene and currently in Phase I for Non-Small Cell Lung Cancer. According to GlobalData,...

Likelihood of Approval and Phase Transition Success Rate Model - BGB-15025 in Non-Small Cell Lung Cancer

Data Insights

BGB-15025 by BeiGene for Gastric Cancer: Likelihood of Approval

BGB-15025 is under clinical development by BeiGene and currently in Phase I for Gastric Cancer. According to GlobalData, Phase I...

Likelihood of Approval and Phase Transition Success Rate Model - BGB-15025 in Gastric Cancer

Data Insights

BGB-15025 by BeiGene for Solid Tumor: Likelihood of Approval

BGB-15025 is under clinical development by BeiGene and currently in Phase I for Solid Tumor. According to GlobalData, Phase I...

Likelihood of Approval and Phase Transition Success Rate Model - BGB-15025 in Solid Tumor

Data Insights

BGB-15025 by BeiGene for Renal Cell Carcinoma: Likelihood of Approval

BGB-15025 is under clinical development by BeiGene and currently in Phase I for Renal Cell Carcinoma. According to GlobalData, Phase...

Data Insights

BGB-15025 by BeiGene for Head And Neck Squamous Cell Carcinoma (HNSC): Likelihood of Approval

BGB-15025 is under clinical development by BeiGene and currently in Phase I for Head And Neck Squamous Cell Carcinoma (HNSC)....

Data Insights

BGB-15025 by BeiGene for Colorectal Cancer: Likelihood of Approval

BGB-15025 is under clinical development by BeiGene and currently in Phase I for Colorectal Cancer. According to GlobalData, Phase I...

Data Insights

BGB-15025 by BeiGene for Cervical Cancer: Likelihood of Approval

BGB-15025 is under clinical development by BeiGene and currently in Phase I for Cervical Cancer. According to GlobalData, Phase I...